These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Author: Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.
    Journal: J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760.
    Abstract:
    OBJECTIVE: The aim of the present study was to examine the in vitro antimicrobial activity of colistin, and ampicillin/sulbactam against A. baumannii isolated from pediatric patients and to compare the susceptibility testing using disc diffusion with minimal inhibitory concentration (MIC) E-test method. MATERIAL AND METHOD: One hundred strains of A. baumannii from various clinical isolates were included in the present study. Antimicrobial susceptibilities of A. baumannii to colistin, ampicillin/sulbactam were determined by disc diffusion and minimal inhibitory concentration (MIC) using E-test method. The analysis was stratified by carbapenem resistance status. Sensitivity and specificity of the disc diffusion test compared to the MIC E-test were estimated. RESULTS: Ninety-seven strains of all isolates (97%) were sensitive to colistin using both disc diffusion and E-test methods. In contrast, 41% and 34% of the isolates were sensitive to ampicillin/sulbactam by disc diffusion and MICE-test, respectively. The colistin MIC50 and MIC90 for A. baumannii were 0.38 and 1 microg/mL, respectively. The ampicillin/sulbactam MIC50 and MIC90 were 16 and 89.6 microg/mL, respectively. Based on the results of MIC E-test, ninety-eight (n = 49) and six (n = 3) percent of carbapenem-resistant A. baumannii (n = 50) were susceptible to colistin and ampicillin/sulbactam, respectively. Sensitivity and specificity of disc diffusion test compared to MIC E-test were 99% and 66.7% for colistin and 80.5% and 98.3% for ampicillin/sulbactam, respectively. CONCLUSION: The antimicrobial activities of colistin against A. baumannii isolates remained high for both cabapenem-susceptible and -resistant strains. However, the in vitro activity of ampicillin/sulbactam against A. baumannii was low. Thus, a combination, rather than monotherapy, of ampicillin/sulbactam with other antibiotics is strongly recommended when dealing with A. baumannii infection. In addition, disc diffusion test appeared to be a useful screening method for susceptibility testing for colistin and ampicillin/sulbactam against A. baumanii.
    [Abstract] [Full Text] [Related] [New Search]